Mission & Description
The Innovative Immuno-Oncology Consortium, located in Santa Monica, CA, is a medical research organization focused on advancing the field of immuno-oncology. Established as a tax-exempt entity in 2025, it aims to foster collaboration and innovation in cancer treatment through research and development initiatives.
Official Records
| EIN | 39-2445499 |
| Subsection | 501(c)(3) |
| Classification | Public Charity |
| NTEE Code | H30 - Medical Research |
| Ruling Date | September 2025 |
| Revocation History | None |
Officers & Directors
No officer compensation data available.
Claim your free profile — add your mission, programs, and donation link. Get a verified badge and full fund accounting from $25/mo.
Claim this profileBank with Holdings and Innovative Immuno-Oncology Consortium automatically receives a 0.5% match every month — funded by Holdings, not you. Your money stays yours.
Support Innovative Immuno-Oncology ConsortiumVerified IRS status, 990 filings, and officer compensation — all free. Holdings indexes every active 501(c)(3) in the US.
Browse CA nonprofits